Why do we help others? Scientists say this part of the brain drives our altruism
The amygdala is not directly responsible for generosity, but plays an essential regulatory role. — AFP
Why do we help others? This question, as old as human society itself, is now being re-examined by an international research team.
Their findings, published in the journal Proceedings of the National Academy of Sciences (PNAS) point to a specific area of the brain.The basolateral amygdala, nestled in the heart of the limbic system, could well play a decisive role in our social behaviour.
Led by Professor Tobias Kalenscher of Heinrich Heine University in Dusseldorf, in collaboration with researchers from the universities of Lausanne, Utrecht and Cape Town, this study is based on the observation of a group of patients with Urbach-Wiethe disease.
This rare genetic condition specifically damages the basolateral amygdala, without affecting other parts of the brain.The scientists wanted to determine how a specific difference in this region of the brain influenced prosocial behaviour.
In order to observe these mechanisms at work, the researchers went to Namaqualand, an isolated region of South Africa home to a community with an unusual concentration of cases of Urbach-Wiethe syndrome.
Although this rare disease has only about 150 recorded cases worldwide, a significant number of sufferers live in this specific area.
On site, scientists have conducted several experiments following a protocol based on a tool well known to behavioural economists: "the dictator game.'
In this game, participants receive a sum of money and must freely decide how much they wish to offer to another person, whether a relative, neighbour or stranger.
The results speak for themselves. Patients with Urbach-Wiethe syndrome show a level of generosity towards their loved ones that is comparable to that of other people.
However, their attitude changes radically when it comes to more distant people.Their generosity drops significantly, as if their brain is unable to adjust their behaviour according to the nature of the emotional bond.
"Individuals with BLA damage were just as generous toward people they were close to as healthy control participants. However, as soon as it came to individuals with whom they had less of an emotional connection, they were notably more selfish,' explains Luca M. Lupken, doctoral student at Heinrich Heine University and co-author of the study, in a press release.
The amygdala is not directly responsible for generosity, but plays an essential regulatory role by adjusting our behaviour according to the degree of social proximity.In other words, it does not orient our morality per se, but influences a person's choice of who they decide to behave altruistically towards.
When it does not function properly, this modulation mechanism can lead to self-centered behaviour. Alterations in this area of the brain could also provide insights into certain disorders, such as autism or psychopathy, in which social decisions frequently deviate from established norms.
For Professor Tobias Kalenscher, these discoveries resonate far beyond the laboratory."Social decisions are not only shaped by our upbringing or culture. They are in fact also strongly anchored in the mechanisms of our brain,' he asserts.
This new understanding of the drivers of altruism could pave the way for targeted interventions capable of restoring a form of social equilibrium among individuals in difficulty.
By refining our knowledge of the link between neuronal structure and behaviour, science could not only discover new therapeutic levers, but also fuel broader reflection on the conditions for a supportive and inclusive society. – AFP Relaxnews
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Borneo Post
30 minutes ago
- Borneo Post
WHO warns of rising Covid-19 cases due to new variant
A picture taken on March 9, 2020 shows the logo of the World Health Organization (WHO) at the entrance of their headquarters in Geneva. – AFP photo WASHINGTON (June 9): The World Health Organisation (WHO) has warned of a rise in COVID-19 infections linked to the emergence of a new variant, NB.1.8.1, which is currently under investigation, Emirates News Agency (WAM) reported. While the organisation confirmed that the new variant does not pose a greater health risk than previous strains, it noted that the continued evolution of the virus could lead to new waves of infection. WHO stated that the current increase aligns with the virus's seasonal pattern and emphasised that the need for hospitalisation or intensive care remains limited due to widespread community immunity and vaccination coverage. The global health body classified the overall global risk level as 'high', urging countries to strengthen health surveillance, integrate COVID-19 into seasonal respiratory disease strategies, combat misinformation, and encourage individuals to adhere to preventive measures. – Bernama-WAM covid-19 health new variant world health organisation
The Star
21 hours ago
- The Star
UN Ocean Conference sets sail in France on World Oceans Day
A protester takes part in the Blue March (Marche Bleue) on the Promenade des Anglais ahead of the United Nations Ocean Conference (Unoc 3), in the French riviera city of Nice, south-eastern France on June 7, 2025. The third edition of the United Nations Ocean Conference (Unoc 3) opens on June 9, 2025, in Nice, where many hope to see money and other concrete actions to protect marine life in polluted, overheated and overfished oceans. -- Photo by Valery HACHE / AFP NICE, France (AP): A fleet of 30 research and exploration vessels from around the world will set sail just off the French coastal city of Nice on Sunday to kick off the third United Nations Ocean Conference and pay tribute to World Oceans Day. The event themed "Ocean Wonders' will see the vessels sail across Nice's Baie des Anges, or Bay of Angels, and is designed to spotlight the beauty and importance of the ocean while urging world leaders not to lose sight of its value as they make decisions about the planet's future. Thousands of delegates, including heads of state, scientists, and environmental advocates, are expected in Nice this week to confront growing threats to the ocean and the need to transform pledges into protection. The UN has called the threats a global emergency facing the world's oceans as they confront rising temperatures, plastic pollution choking marine life, and relentless overexploitation of fish and other resources. Just 2.7% of the global ocean is effectively protected from destructive activities like industrial fishing and deep-sea mining - far below the global goal of 30% by 2030. Participating boats include the Energy Observer, a solar-panel covered catamaran that was the first vessel to circumnavigate the globe using renewable energy alone. It produces hydrogen fuel on board via seawater electrolysis, offering a vision of zero-emissions maritime travel. Other standout vessels include France's Alfred Merlin, dedicated to underwater archaeology; the OceanXplorer, a high-tech billionaire-owned research yacht; and the WWF's Blue Panda, which is working to map and protect the last remaining seagrass meadows in the Mediterranean Sea. At the heart of the conference is the push to ratify the High Seas Treaty, adopted in 2023. If it enters into force, the treaty would for the first time allow countries to establish marine protected areas in international waters, which cover nearly two-thirds of the ocean and remain largely ungoverned. "The High Seas Treaty is critical to ensuring we can protect biodiversity in the ocean,' said Rebecca Hubbard, director of the High Seas Alliance. "We're in the middle of a biodiversity and climate crisis. We absolutely have to protect the ocean to address those crises.' But even in waters already designated as protected, enforcement often falls short. Many countries, France included, face criticism from environmental groups over weak regulation and continued industrial activity within their marine protected areas. "The ambition is not there, the speed is not there, and the scale has not been there,' said Sílvia Tavares, project manager at Oceano Azul Foundation. "Moments like UNOC are key to changing that.' Several countries are expected to announce new marine protected areas during the conference, along with bans on bottom trawling and other destructive activities within their existing MPA networks. After Sunday's parade sail, the "Ocean Wonders' fleet will remain docked in Nice and open to the public until the conference concludes on June 13. - AP
The Star
21 hours ago
- The Star
Man who let snakes bite him 200 times spurs new antivenom hope
SOUTH-EAST ASIA/PARIS (AFP): Tim Friede was feeling particularly down on the day after the September 11 attacks, so he went to his basement and let two of the world's deadliest snakes bite him. Four days later, he woke up from a coma. "I know what it feels like to die from snakebite," Friede told AFP via video call from his home in the small US town of Two Rivers, Wisconsin. This experience might put most people off snakes entirely, but Friede simply vowed to be more careful next time. From 2000 to 2018, he allowed himself to be bitten by snakes more than 200 times. He also injected himself with their venom over 650 times. Friede endured this pain because he wanted to achieve total immunity to venom, a practice called mithridatism which should not be tried at home. After a couple of years, Friede started to believe he could be the basis for a better kind of antivenom. The former truck mechanic, who does not have a university degree, long struggled to be taken seriously by scientists. But last month, a study published in the prestigious Cell journal showed that antibodies from his blood protect against a range of snake venom. The researchers now hope Friede's hyper-immunity could even lead to the development of a universal antivenom. This would fill a major need, because currently most antivenoms only cover one or a few of the world's 600 venomous snakes. Up to 138,000 people are killed by snakebites a year, while 400,000 suffer amputations or other disabilities, according to the World Health Organization. These figures are believed to be vastly underestimated because snakebite victims typically live in poorer, remote areas. - 'Pain every time' - Friede's first bite was from a harmless garter snake when he was five years old. "I was afraid, I cried, I ran away," said Friede, now 57. Then he started bringing snakes home and hiding them in pickle jars. His mother sought counselling, but his interest in snakes persisted. Things escalated after Friede attended a class that taught him how to "milk" snakes for their venom. How antivenom is made has changed little over the last 125 years. Small doses of snake venom are injected into animals such as horses, which produce antibodies that can be extracted and used as antivenom. Researchers hope Friede's hyper-immunity could even lead to the development of a universal anti-venom. -- PHOTO: AFP However this antivenom usually only works for bites from that particular species of snake -- and it includes other antibodies from horse that can cause serious side-effects including anaphylactic shock. "I thought, well, if they make antivenom in horses, why can't I just use myself as a primate?" Friede said. He started working through the venom from all the deadly species he could get his hands on, such as cobras, taipans, black mambas and rattlesnakes. "There is pain every time," he said. - 'Proud' - For years, the scientists he contacted to take advantage of his immunity refused to bite. Then in 2017, immunologist Jacob Glanville, who previously worked on universal vaccines, turned his attention towards antivenom. Glanville told AFP he had been looking for "a clumsy snake researcher who'd been bit accidentally a couple times," when he came across a video of Friede taking brutal back-to-back snake bites. When they first spoke, Glanville said he told Friede: "I know this is awkward, but I would love to get my hands on some of your blood." "I've been waiting for this call for a long time," came the response, Glanville said. The antivenom described in the Cell paper includes two antibodies from Friede's blood, as well as a drug called varespladib. It offered mice full protection against 13 of the 19 snake species tested, and partial protection for the remaining six. The researchers hope a future cocktail will cover far more snakes -- particularly vipers -- with further trials planned on dogs in Australia. Timothy Jackson of the Australian Venom Research Unit praised the immunological research, but questioned whether a human needed to be involved, pointing to synthetically developed antibodies. Glanville said the ultimate goal of his US-based firm Centivax was to develop a universal antivenom administered by something like an EpiPen, potentially produced in India to keep the costs down. Friede said he was "proud" to have made a "small difference" in medical history. Now working for Centivax, Friede stopped self-inflicting himself with venom in 2018 to save the firm from liability issues. But he hopes to get bitten by snakes again in the future. "I do miss it," he said. - AFP
